Effect of the LPA‑mediated CXCL12‑CXCR4 axis in the tumor proliferation, migration and invasion of ovarian cancer cell lines

Wang,Hui; Liu,Wenli; Wei,Dongmin; Hu,Kun; Wu,Xiaohua; Yao,Yuanqing

doi:10.3892/ol.2014.1926

Effect of the LPA‑mediated CXCL12‑CXCR4 axis in the tumor proliferation, migration and invasion of ovarian cancer cell lines

Authors:
- Hui Wang
- Wenli Liu
- Dongmin Wei
- Kun Hu
- Xiaohua Wu
- Yuanqing Yao
View Affiliations

Affiliations: Department of Obstetrics and Gynaecology, General Hospital of PLA, Beijing 100853, P.R. China, Affiliated Hospital of Hebei University of Engineering, Handan, Hebei 056002, P.R. China, Department of Obstetrics and Gynaecology, Shijingshan Teaching Hospital of Capital Medical University, Beijing Shijingshan Hospital, Beijing 100043, P.R. China, Department of Obstetrics and Gynaecology, Bethune International Peace Hospital of PLA, Shijiazhuang, Hebei 050000, P.R. China
Published online on: February 28, 2014 https://doi.org/10.3892/ol.2014.1926
Pages: 1581-1585

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Ovarian cancer is the most fatal gynecological cancer, with a 5‑year survival rate of only 30%. Lysophosphatidic acid (LPA), which possesses growth factor‑like functions, is a major regulatory factor in the peritoneal metastasis of ovarian cancer. LPA stimulates the expression of numerous genes that are associated with angiogenesis and metastasis. Ovarian epithelial carcinoma specifically expresses chemotactic factor C‑X‑C motif chemokine ligand 12 (CXCL12) and its receptor, CXC receptor 4 (CXCR4). The CXCL12‑CXCR4 axis directly contributes to ovarian cancer cell proliferation, migration and invasion. The present study investigated the regulation of LPA on the CXCL12‑CXCR4 axis and the effect of the LPA‑mediated CXCL12‑CXCR4 axis on the tumor proliferation, migration and invasion of ovarian cancer cell lines. The CXCR4 proteins expressed in the cell membrane and the cytoplasm of ovarian cancer cells, CAOV3 and SKOV3, were detected by immunocytochemistry. The expression of CXCR4 and CXCL12 was increased in the ovarian cancer cells in a dose‑ and time‑dependent manner when treated with LPA compared with the control groups (P<0.05), as determined by reverse transcription polymerase chain reaction and flow cytometry. LPA (20 µM) and CXCL12 (100 ng/ml) enhanced the proliferation, migration and invasion of the ovarian cancer cells, CAOV3 and SKOV3, as identified by MTT, Transwell and Matrigel assays following co‑treatment for 24 h. LPA promoted invasiveness of ovarian cancer by upregulating CXCL12‑CXCR4 axis expression.

View Figures

View References

1	Xu Y, Gaudette DC, Boynton JD, et al: Characterization of an ovarian cancer activating factor in ascites from ovarian cancer patients. Clin Cancer Res. 1:1223–1232. 1995.PubMed/NCBI
2	Xu Y, Shen Z, Wiper DW, et al: Lysophosphatidic acid as a potential biomarker for ovarian and other gynecologic cancers. JAMA. 280:719–723. 1998. View Article : Google Scholar
3	Hu YL, Albanese C, Pestell RG and Jaffe RB: Dual mechanisms for lysophosphatidic acid stimulation of human ovarian carcinoma cells. J Natl Cancer Inst. 95:733–740. 2003. View Article : Google Scholar : PubMed/NCBI
4	Frankel A and Mills GB: Peptide and lipid growth factors decrease cis-diamminedichloroplatinum-induced cell death in human ovarian cancer cells. Clin Cancer Res. 2:1307–1313. 1996.PubMed/NCBI
5	Pustilnik TB, Estrella V, Wiener JR, et al: Lysophosphatidic acid induces urokinase secretion by ovarian cancer cells. Clin Cancer Res. 5:3704–3710. 1999.PubMed/NCBI
6	Fujita T, Miyamoto S, Onoyama I, Sonoda K, Mekada E and Nakano H: Expression of lysophosphatidic acid receptors and vascular endothelial growth factor mediating lysophosphatidic acid in the development of human ovarian cancer. Cancer Lett. 192:161–169. 2003. View Article : Google Scholar
7	Fishman DA, Liu Y, Ellerbroek SM and Stack MS: Lysophosphatidic acid promotes matrix metalloproteinase (MMP) activation and MMP-dependent invasion in ovarian cancer cells. Cancer Res. 61:3194–3199. 2001.PubMed/NCBI
8	So J, Navari J, Wang FQ and Fishman DA: Lysophosphatidic acid enhances epithelial ovarian carcinoma invasion through the increased expression of interleukin-8. Gynecol Oncol. 95:314–322. 2004. View Article : Google Scholar : PubMed/NCBI
9	Symowicz J, Adley BP, Woo MM, Auersperg N, Hudson LG and Stack MS: Cyclooxygenase-2 functions as a downstream mediator of lysophosphatidic acid to promote aggressive behavior in ovarian carcinoma cells. Cancer Res. 65:2234–2242. 2005. View Article : Google Scholar
10	Scotton CJ, Wilson JL, Milliken D, Stamp G and Balkwill FR: Epithelial cancer cell migration: a role for chemokine receptors? Cancer Res. 61:4961–4965. 2001.PubMed/NCBI
11	Scotton CJ, Wilson JL, Scott K, et al: Multiple actions of the chemokine CXCL12 on epithelial tumor cells in human ovarian cancer. Cancer Res. 62:5930–5938. 2002.
12	Dewan MZ, Ahmed S, Iwasaki Y, Ohba K, Toi M and Yamamoto N: Stromal cell-derived factor-1 and CXCR4 receptor interaction in tumor growth and metastasis of breast cancer. Biomed Pharmacother. 60:273–276. 2006. View Article : Google Scholar
13	Jiang YP, Wu XH, Shi B, Wu WX and Yin GR: Expression of chemokine CXCL12 and its receptor CXCR4 in human epithelial ovarian cancer: an independent prognostic factor for tumor progression. Gynecol Oncol. 103:226–233. 2006. View Article : Google Scholar : PubMed/NCBI
14	Jemal A, Thomas A, Murray T and Thun M: Cancer statistics, 2002. CA Cancer J Clin. 52:23–47. 2002. View Article : Google Scholar
15	Popple A, Durrant LG, Spendlove I, et al: The chemokine, CXCL12, is an independent predictor of poor survival in ovarian cancer. Br J Cancer. 106:1306–1313. 2012. View Article : Google Scholar
16	Müller A, Homey B, Soto H, et al: Involvement of chemokine receptors in breast cancer metastasis. Nature. 410:50–56. 2001.PubMed/NCBI
17	Phillips RJ, Burdick MD, Lutz M, Belperio JA, Keane MP and Strieter RM: The stromal derived factor-1/CXCL12-CXC chemokine receptor 4 biological axis in non-small cell lung cancer metastases. Am J Respir Crit Care Med. 167:1676–1686. 2003. View Article : Google Scholar : PubMed/NCBI
18	Cooper CR, Chay CH, Gendernalik JD, et al: Stromal factors involved in prostate carcinoma metastasis to bone. Cancer. 97(3 Suppl): 739–747. 2003. View Article : Google Scholar : PubMed/NCBI
19	Kryczek I, Wei S, Keller E, Liu R and Zou W: Stroma-derived factor (SDF-1/CXCL12) and human tumor pathogenesis. Am J Physiol Cell Physiol. 292:C987–C995. 2007. View Article : Google Scholar : PubMed/NCBI
20	Guo L, Cui ZM, Zhang J and Huang Y: Chemokine axes CXCL12/CXCR4 and CXCL16/CXCR6 correlate with lymph node metastasis in epithelial ovarian carcinoma. Chin J Cancer. 30:336–343. 2011. View Article : Google Scholar : PubMed/NCBI
21	Daaka Y: Mitogenic action of LPA in prostate. Biochim Biophys Acta. 1582:265–269. 2002. View Article : Google Scholar : PubMed/NCBI
22	Gräler MH and Goetzl EJ: Lysophospholipids and their G protein-coupled receptors in inflammation and immunity. Biochim Biophys Acta. 1582:168–174. 2002.PubMed/NCBI
23	Ren J, Xiao YJ, Singh LS, et al: Lysophosphatidic acid is constitutively produced by human peritoneal mesothelial cells and enhances adhesion, migration, and invasion of ovarian cancer cells. Cancer Res. 66:3006–3014. 2006. View Article : Google Scholar
24	Moolenaar WH: Bioactive lysophospholipids and their G protein-coupled receptors. Exp Cell Res. 253:230–238. 1999. View Article : Google Scholar : PubMed/NCBI
25	Ishii S, Noguchi K and Yanagida K: Non-Edg family lysophosphatidic acid (LPA) receptors. Prostaglandins Other Lipid Mediat. 89:57–65. 2009. View Article : Google Scholar : PubMed/NCBI
26	Yanagida K, Kurikawa Y, Shimizu T and Ishii S: Current progress in non-Edg family LPA receptor research. Biochim Biophys Acta. 1831:33–41. 2013. View Article : Google Scholar : PubMed/NCBI
27	Gunther EC, von Bartheld CS, Goodman LJ, Johnson JE and Bothwell M: The G-protein inhibitor, pertussis toxin, inhibits the secretion of brain-derived neurotrophic factor. Neuroscience. 100:569–579. 2000. View Article : Google Scholar : PubMed/NCBI